Sipuleucel-T (Provenge®)—Autopsy of an Innovative Paradigm Change in Cancer Treatment: Why a Single-Product Biotech Company Failed to Capitalize on its Breakthrough Invention
Pharmacovigilance Considerations for Biosimilars in the USA
FDA Draft Guidance on the Naming of Biosimilars
Selective Phosphodiesterase Inhibitors for Psoriasis: Focus on Apremilast
Ramucirumab: A Review in Advanced Gastric Cancer
Bivalent rLP2086 Vaccine (Trumenba®): A Review in Active Immunization Against Invasive Meningococcal Group B Disease in Individuals Aged 10-25 Years